+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Artery Disease Market By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 280 Pages
  • April 2024
  • Region: Global
  • Allied Market Research
  • ID: 6010515
Description Jump to:
The global peripheral artery disease market was valued at $4.5 billion in 2023, and is estimated to reach $10.8 billion by 2035, growing at a CAGR of 7.7% from 2024 to 2035. Peripheral artery disease is a condition characterized by the narrowing or blockage of arteries that supply blood to the limbs, typically the legs. This occurs due to the buildup of fatty deposits (plaques) in the arteries, a process known as atherosclerosis. As a result, blood flow to the legs is restricted, leading to symptoms such as leg pain, cramping, numbness, and weakness, particularly during physical activity. Treatment for peripheral artery disease aims to manage symptoms, prevent complications, and improve blood flow. Procedures or surgeries may be required to open blocked arteries and restore blood flow. These can include angioplasty (where a balloon is used to widen the artery) or stent placement (to keep the artery open).

The peripheral artery disease market growth is attributed to rise in geriatric population, and technological advancements in minimally invasive surgical technology. According to 2022 report by World Health Organization, it was estimated that, the geriatric population (aged 60 and above) is expected to contribute about 22% of global population. As people age, the risk of developing peripheral artery disease rises, especially among those with other cardiovascular risk factors such as diabetes, hypertension, and smoking history. With populations in many countries experiencing a demographic shift towards older age brackets, the incidence and prevalence of peripheral artery disease are expected to escalate. According to the 2023 report by the National Library of Medicine, it was reported that incidence of peripheral artery disease increases to as high as 20% in people over the age of 70. Thus, as the geriatric population has a higher incidence rate of peripheral artery disease, the rise in geriatric population is expected to positively impact the growth of peripheral artery disease market.In addition, technological advancements in minimally invasive procedures have emerged as a major driver for the peripheral artery disease market, transforming the landscape of diagnosis and treatment. Minimally invasive techniques, such as angioplasty, stenting, and atherectomy, have revolutionized the management of peripheral artery disease by offering safer and more effective alternatives to traditional open surgeries. These procedures involve smaller incisions, reduced trauma to surrounding tissues, shorter recovery times, and lower risk of complications compared to conventional surgical approaches. For instance, Medtronic Plc, a leading medical devices company, provides a complete SE vascular stent system. The complete SE vascular stent system is designed to treat peripheral arterial disease in the superficial femoral arteries and proximal popliteal arteries. The stent is designed to open clogged arteries and restore blood flow by providing support to the artery after angioplasty. Thus, the advantages of minimally invasive procedures such as shorter hospital stays and reduced physical trauma (caused in traditional open surgery) are expected to drive the growth of the market.The peripheral artery disease market is segmented by product type, end user, and region. By product type the market is bifurcated into drugs and devices. By end user, the market is divided into hospitals, specialized clinics and ambulatory surgeries centers. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA). Major key players that operate in the peripheral artery disease market are Philips N.V., Braun Melsungen AG, Medtronic, Bayer AG, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Medical Corporation, Biotronik, Cardinal Health, Abbott. Key players have adopted product approval as a key developmental strategy to improve the product portfolio of the peripheral artery disease marketKey Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the peripheral artery disease market analysis from 2023 to 2035 to identify the prevailing peripheral artery disease market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the peripheral artery disease market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global peripheral artery disease market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Devices
  • Devices type
  • Peripheral Angioplasty Balloons
  • Peripheral Stents
  • Peripheral Catheters
  • Inferior Vena Cava Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories
  • Drugs
  • Drug Type
  • Antiplatelet medicines
  • Statins
  • Anti Hypertensive Medication
  • Others

By End User

  • Specialty Clinics
  • Hospitals

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Koninklijke Philips N.V.
  • B. Braun Melsungen AG
  • Medtronic
  • Bayer AG
  • Boston Scientific Corporation
  • Becton Dickinson and Company
  • Terum
  • Medical Corporation
  • Biotronik SE & Co. KG
  • Cardinal Health
  • Abbott Laboratories

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: PERIPHERAL ARTERY DISEASE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Devices Peripheral Artery Disease Market by Devices type
4.3. Drugs
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Drugs Peripheral Artery Disease Market by Drug Type
CHAPTER 5: PERIPHERAL ARTERY DISEASE MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Specialty Clinics
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PERIPHERAL ARTERY DISEASE MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Product Type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Product Type
6.2.4.1.2. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Product Type
6.2.4.2.2. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Product Type
6.2.4.3.2. Market size and forecast, by End User
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Product Type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Product Type
6.3.4.1.2. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Product Type
6.3.4.2.2. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Product Type
6.3.4.3.2. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Product Type
6.3.4.4.2. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Product Type
6.3.4.5.2. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Product Type
6.3.4.6.2. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Product Type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Product Type
6.4.4.1.2. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Product Type
6.4.4.2.2. Market size and forecast, by End User
6.4.4.3. Australia
6.4.4.3.1. Market size and forecast, by Product Type
6.4.4.3.2. Market size and forecast, by End User
6.4.4.4. India
6.4.4.4.1. Market size and forecast, by Product Type
6.4.4.4.2. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Product Type
6.4.4.5.2. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Product Type
6.4.4.6.2. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Product Type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Product Type
6.5.4.1.2. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Product Type
6.5.4.2.2. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Product Type
6.5.4.3.2. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Product Type
6.5.4.4.2. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Koninklijke Philips N.V.
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Medtronic
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Bayer AG
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Becton Dickinson and Company
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Terumo Medical Corporation
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Biotronik SE & Co. KG
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Cardinal Health
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Abbott Laboratories
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 02. Peripheral Artery Disease Market for Devices, by Region, 2023-2035 ($Million)
Table 03. Global Devices Peripheral Artery Disease Market, by Devices Type, 2023-2035 ($Million)
Table 04. Peripheral Artery Disease Market for Drugs, by Region, 2023-2035 ($Million)
Table 05. Global Drugs Peripheral Artery Disease Market, by Drug Type, 2023-2035 ($Million)
Table 06. Global Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 07. Peripheral Artery Disease Market for Hospitals, by Region, 2023-2035 ($Million)
Table 08. Peripheral Artery Disease Market for Specialty Clinics, by Region, 2023-2035 ($Million)
Table 09. Peripheral Artery Disease Market, by Region, 2023-2035 ($Million)
Table 10. North America Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 11. North America Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 12. North America Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 13. U.S. Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 14. U.S. Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 15. Canada Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 16. Canada Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 17. Mexico Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 18. Mexico Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 19. Europe Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 20. Europe Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 21. Europe Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 22. Germany Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 23. Germany Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 24. France Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 25. France Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 26. UK Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 27. UK Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 28. Italy Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 29. Italy Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 30. Spain Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 31. Spain Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 32. Rest of Europe Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 33. Rest of Europe Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 34. Asia-Pacific Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 35. Asia-Pacific Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 36. Asia-Pacific Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 37. Japan Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 38. Japan Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 39. China Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 40. China Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 41. Australia Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 42. Australia Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 43. India Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 44. India Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 45. South Korea Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 46. South Korea Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 47. Rest of Asia-Pacific Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 48. Rest of Asia-Pacific Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 49. LAMEA Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 50. LAMEA Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 51. LAMEA Peripheral Artery Disease Market, by Country, 2023-2035 ($Million)
Table 52. Brazil Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 53. Brazil Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 54. Saudi Arabia Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 55. Saudi Arabia Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 56. South Africa Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 57. South Africa Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 58. Rest of LAMEA Peripheral Artery Disease Market, by Product Type, 2023-2035 ($Million)
Table 59. Rest of LAMEA Peripheral Artery Disease Market, by End-user, 2023-2035 ($Million)
Table 60. Koninklijke Philips N.V.: Key Executives
Table 61. Koninklijke Philips N.V.: Company Snapshot
Table 62. Koninklijke Philips N.V.: Product Segments
Table 63. Koninklijke Philips N.V.: Service Segments
Table 64. Koninklijke Philips N.V.: Product Portfolio
Table 65. Koninklijke Philips N.V.: Key Strategies
Table 66. B. Braun Melsungen AG: Key Executives
Table 67. B. Braun Melsungen AG: Company Snapshot
Table 68. B. Braun Melsungen AG: Product Segments
Table 69. B. Braun Melsungen AG: Service Segments
Table 70. B. Braun Melsungen AG: Product Portfolio
Table 71. B. Braun Melsungen AG: Key Strategies
Table 72. Medtronic: Key Executives
Table 73. Medtronic: Company Snapshot
Table 74. Medtronic: Product Segments
Table 75. Medtronic: Service Segments
Table 76. Medtronic: Product Portfolio
Table 77. Medtronic: Key Strategies
Table 78. Bayer AG: Key Executives
Table 79. Bayer AG: Company Snapshot
Table 80. Bayer AG: Product Segments
Table 81. Bayer AG: Service Segments
Table 82. Bayer AG: Product Portfolio
Table 83. Bayer AG: Key Strategies
Table 84. Boston Scientific Corporation: Key Executives
Table 85. Boston Scientific Corporation: Company Snapshot
Table 86. Boston Scientific Corporation: Product Segments
Table 87. Boston Scientific Corporation: Service Segments
Table 88. Boston Scientific Corporation: Product Portfolio
Table 89. Boston Scientific Corporation: Key Strategies
Table 90. Becton Dickinson and Company: Key Executives
Table 91. Becton Dickinson and Company: Company Snapshot
Table 92. Becton Dickinson and Company: Product Segments
Table 93. Becton Dickinson and Company: Service Segments
Table 94. Becton Dickinson and Company: Product Portfolio
Table 95. Becton Dickinson and Company: Key Strategies
Table 96. Terumo Medical Corporation: Key Executives
Table 97. Terumo Medical Corporation: Company Snapshot
Table 98. Terumo Medical Corporation: Product Segments
Table 99. Terumo Medical Corporation: Service Segments
Table 100. Terumo Medical Corporation: Product Portfolio
Table 101. Terumo Medical Corporation: Key Strategies
Table 102. Biotronik SE & Co. KG: Key Executives
Table 103. Biotronik SE & Co. KG: Company Snapshot
Table 104. Biotronik SE & Co. KG: Product Segments
Table 105. Biotronik SE & Co. KG: Service Segments
Table 106. Biotronik SE & Co. KG: Product Portfolio
Table 107. Biotronik SE & Co. KG: Key Strategies
Table 108. Cardinal Health: Key Executives
Table 109. Cardinal Health: Company Snapshot
Table 110. Cardinal Health: Product Segments
Table 111. Cardinal Health: Service Segments
Table 112. Cardinal Health: Product Portfolio
Table 113. Cardinal Health: Key Strategies
Table 114. Abbott Laboratories: Key Executives
Table 115. Abbott Laboratories: Company Snapshot
Table 116. Abbott Laboratories: Product Segments
Table 117. Abbott Laboratories: Service Segments
Table 118. Abbott Laboratories: Product Portfolio
Table 119. Abbott Laboratories: Key Strategies
List of Figures
Figure 01. Peripheral Artery Disease Market, 2023-2035
Figure 02. Segmentation of Peripheral Artery Disease Market,2023-2035
Figure 03. Top Impacting Factors in Peripheral Artery Disease Market
Figure 04. Top Investment Pockets in Peripheral Artery Disease Market (2024-2035)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Peripheral Artery Disease Market:Drivers, Restraints and Opportunities
Figure 11. Peripheral Artery Disease Market, by Product Type, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Peripheral Artery Disease Market for Devices, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Peripheral Artery Disease Market for Drugs, by Country 2023 and 2035(%)
Figure 14. Peripheral Artery Disease Market, by End-user, 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Peripheral Artery Disease Market for Hospitals, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Peripheral Artery Disease Market for Specialty Clinics, by Country 2023 and 2035(%)
Figure 17. Peripheral Artery Disease Market by Region, 2023 and 2035(%)
Figure 18. U.S. Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 19. Canada Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 20. Mexico Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 21. Germany Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 22. France Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 23. UK Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 24. Italy Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 25. Spain Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 26. Rest of Europe Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 27. Japan Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 28. China Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 29. Australia Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 30. India Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 31. South Korea Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 32. Rest of Asia-Pacific Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 33. Brazil Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 34. Saudi Arabia Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 35. South Africa Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 36. Rest of LAMEA Peripheral Artery Disease Market, 2023-2035 ($Million)
Figure 37. Top Winning Strategies, by Year
Figure 38. Top Winning Strategies, by Development
Figure 39. Top Winning Strategies, by Company
Figure 40. Product Mapping of Top 10 Players
Figure 41. Competitive Dashboard
Figure 42. Competitive Heatmap: Peripheral Artery Disease Market
Figure 43. Top Player Positioning, 2023

Companies Mentioned

Key Market Players in the Peripheral Artery Disease Market include:
  • Koninklijke Philips N.V.
  • B. Braun Melsungen AG
  • Medtronic
  • Bayer AG
  • Boston Scientific Corporation
  • Becton Dickinson and Company
  • Terumo Medical Corporation
  • Biotronik SE & Co. KG
  • Cardinal Health
  • Abbott Laboratories

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages280
PublishedApril 2024
Forecast Period2023 - 2035
Estimated Market Value ( USD ) in 2023 $ 4.5 billion
Forecasted Market Value ( USD ) by 2035 $ 10.8 billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Peripheral Artery Disease Market Report by Type Filters, End User, and Region 2024-2032 - Product Image

Peripheral Artery Disease Market Report by Type Filters, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 295 Pages
  • Global
From
Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030 - Product Image

Peripheral Arterial Disease Therapeutics Market by Treatment Type, Indication Stage, End-Users - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
End-Stage Coronary Artery Disease - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

End-Stage Coronary Artery Disease - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Carotid Artery Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Carotid Artery Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.